Vascularization: regenerative medicine and tissue engineering
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Boca Raton, FL
Taylor & Francis/CRC Press
2014
|
| Schlagworte: | |
| Online-Zugang: | DE-91 Volltext |
| Beschreibung: | Includes bibliographical references and index "The first federally-funded meeting on tissue engineering was in 1988. In this and subsequent meetings, the fields of tissue engineering and regenerative medicine (TERM) have been described as having the potential to revolutionize clinical approaches to the replacement, reconstruction or regeneration of organs and tissues. While TERM research has resulted in new patient treatments, the broad impact on clinical practice envisioned has not been achieved. The development of new TERM therapies that have significant clinical impact requires the ability to control vascularization, the process of new vessel assembly. The circulatory system plays a number of vital roles in regenerating and functioning tissues. It supplies oxygen and nutrients, removes wastes and is a source of multiple cell types required to respond to changing physiological conditions. For nearly every TERM application, the ability to enhance, regenerate or engineer new tissues requires spatial and temporal control over the process of vascularization. While vascularization is being studied in a number of physiologic and pathologic processes, TERM applications present distinct challenges. For example, unique microenvironmental conditions result from biomaterial and cell combinations used in TERM applications that are not encountered in any other system. In addition, clinical applications require vascularization of large tissue volumes within time frames that are much lower than those found during vascularization in development and typical physiologic processes. These requirements place significant constraints on the design of TERM therapies"--Provided by publisher Section 1. Cells -- section 2. Biomaterials -- section 3. Models -- section 4. Imaging -- section 5. Vascularized tissues |
| Beschreibung: | 1 Online-Ressource |
| ISBN: | 1466580453 1466580461 9781466580459 9781466580466 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV042793936 | ||
| 003 | DE-604 | ||
| 005 | 20151019 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 150902s2014 xx o|||| 00||| eng d | ||
| 020 | |a 1466580453 |9 1-4665-8045-3 | ||
| 020 | |a 1466580461 |9 1-4665-8046-1 | ||
| 020 | |a 9781466580459 |9 978-1-4665-8045-9 | ||
| 020 | |a 9781466580466 |9 978-1-4665-8046-6 | ||
| 035 | |a (OCoLC)881462033 | ||
| 035 | |a (DE-599)BVBBV042793936 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-91 | ||
| 082 | 0 | |a 616.1/3 |2 23 | |
| 245 | 1 | 0 | |a Vascularization |b regenerative medicine and tissue engineering |c editor, Eric M. Brey |
| 264 | 1 | |a Boca Raton, FL |b Taylor & Francis/CRC Press |c 2014 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a "The first federally-funded meeting on tissue engineering was in 1988. In this and subsequent meetings, the fields of tissue engineering and regenerative medicine (TERM) have been described as having the potential to revolutionize clinical approaches to the replacement, reconstruction or regeneration of organs and tissues. While TERM research has resulted in new patient treatments, the broad impact on clinical practice envisioned has not been achieved. The development of new TERM therapies that have significant clinical impact requires the ability to control vascularization, the process of new vessel assembly. The circulatory system plays a number of vital roles in regenerating and functioning tissues. It supplies oxygen and nutrients, removes wastes and is a source of multiple cell types required to respond to changing physiological conditions. For nearly every TERM application, the ability to enhance, regenerate or engineer new tissues requires spatial and temporal control over the process of vascularization. While vascularization is being studied in a number of physiologic and pathologic processes, TERM applications present distinct challenges. For example, unique microenvironmental conditions result from biomaterial and cell combinations used in TERM applications that are not encountered in any other system. In addition, clinical applications require vascularization of large tissue volumes within time frames that are much lower than those found during vascularization in development and typical physiologic processes. These requirements place significant constraints on the design of TERM therapies"--Provided by publisher | ||
| 500 | |a Section 1. Cells -- section 2. Biomaterials -- section 3. Models -- section 4. Imaging -- section 5. Vascularized tissues | ||
| 650 | 4 | |a Vascular Surgical Procedures / methods | |
| 650 | 4 | |a Blood Vessels / anatomy & histology | |
| 650 | 4 | |a Regenerative Medicine / methods | |
| 650 | 4 | |a Tissue Engineering / methods | |
| 650 | 4 | |a Tissue Transplantation | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / General |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Clinical Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Diseases |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Evidence-Based Medicine |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Internal Medicine |2 bisacsh | |
| 650 | 7 | |a Blood-vessels / Surgery |2 fast | |
| 650 | 7 | |a Regenerative medicine |2 fast | |
| 650 | 7 | |a Tissue engineering |2 fast | |
| 650 | 4 | |a Evidenz-basierte Medizin | |
| 650 | 4 | |a Innere Medizin | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Blood-vessels |x Surgery | |
| 650 | 4 | |a Regenerative medicine | |
| 650 | 4 | |a Tissue engineering | |
| 650 | 0 | 7 | |a Tissue Engineering |0 (DE-588)4646061-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Vaskularisation |0 (DE-588)4187429-8 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Vaskularisation |0 (DE-588)4187429-8 |D s |
| 689 | 0 | 1 | |a Tissue Engineering |0 (DE-588)4646061-5 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Brey, Eric M. |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=798050 |x Aggregator |3 Volltext |
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 912 | |a ZDB-4-NLEBK | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-028223709 | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=798050 |l DE-91 |p ZDB-4-NLEBK |q TUM_PDA_EBSCOMED_gekauft |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1823056933481873408 |
|---|---|
| adam_text | |
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV042793936 |
| collection | ZDB-4-NLEBK |
| ctrlnum | (OCoLC)881462033 (DE-599)BVBBV042793936 |
| dewey-full | 616.1/3 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.1/3 |
| dewey-search | 616.1/3 |
| dewey-sort | 3616.1 13 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000zc 4500</leader><controlfield tag="001">BV042793936</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20151019</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150902s2014 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1466580453</subfield><subfield code="9">1-4665-8045-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1466580461</subfield><subfield code="9">1-4665-8046-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781466580459</subfield><subfield code="9">978-1-4665-8045-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781466580466</subfield><subfield code="9">978-1-4665-8046-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)881462033</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042793936</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.1/3</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Vascularization</subfield><subfield code="b">regenerative medicine and tissue engineering</subfield><subfield code="c">editor, Eric M. Brey</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton, FL</subfield><subfield code="b">Taylor & Francis/CRC Press</subfield><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"The first federally-funded meeting on tissue engineering was in 1988. In this and subsequent meetings, the fields of tissue engineering and regenerative medicine (TERM) have been described as having the potential to revolutionize clinical approaches to the replacement, reconstruction or regeneration of organs and tissues. While TERM research has resulted in new patient treatments, the broad impact on clinical practice envisioned has not been achieved. The development of new TERM therapies that have significant clinical impact requires the ability to control vascularization, the process of new vessel assembly. The circulatory system plays a number of vital roles in regenerating and functioning tissues. It supplies oxygen and nutrients, removes wastes and is a source of multiple cell types required to respond to changing physiological conditions. For nearly every TERM application, the ability to enhance, regenerate or engineer new tissues requires spatial and temporal control over the process of vascularization. While vascularization is being studied in a number of physiologic and pathologic processes, TERM applications present distinct challenges. For example, unique microenvironmental conditions result from biomaterial and cell combinations used in TERM applications that are not encountered in any other system. In addition, clinical applications require vascularization of large tissue volumes within time frames that are much lower than those found during vascularization in development and typical physiologic processes. These requirements place significant constraints on the design of TERM therapies"--Provided by publisher</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Section 1. Cells -- section 2. Biomaterials -- section 3. Models -- section 4. Imaging -- section 5. Vascularized tissues</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Vascular Surgical Procedures / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Blood Vessels / anatomy & histology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Regenerative Medicine / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tissue Engineering / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tissue Transplantation</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Clinical Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Diseases</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Evidence-Based Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Internal Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Blood-vessels / Surgery</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Regenerative medicine</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tissue engineering</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Evidenz-basierte Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Innere Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Blood-vessels</subfield><subfield code="x">Surgery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Regenerative medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tissue engineering</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tissue Engineering</subfield><subfield code="0">(DE-588)4646061-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Vaskularisation</subfield><subfield code="0">(DE-588)4187429-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Vaskularisation</subfield><subfield code="0">(DE-588)4187429-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Tissue Engineering</subfield><subfield code="0">(DE-588)4646061-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brey, Eric M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=798050</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028223709</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=798050</subfield><subfield code="l">DE-91</subfield><subfield code="p">ZDB-4-NLEBK</subfield><subfield code="q">TUM_PDA_EBSCOMED_gekauft</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV042793936 |
| illustrated | Not Illustrated |
| indexdate | 2025-02-03T17:09:34Z |
| institution | BVB |
| isbn | 1466580453 1466580461 9781466580459 9781466580466 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028223709 |
| oclc_num | 881462033 |
| open_access_boolean | |
| owner | DE-91 DE-BY-TUM |
| owner_facet | DE-91 DE-BY-TUM |
| physical | 1 Online-Ressource |
| psigel | ZDB-4-NLEBK ZDB-4-NLEBK TUM_PDA_EBSCOMED_gekauft |
| publishDate | 2014 |
| publishDateSearch | 2014 |
| publishDateSort | 2014 |
| publisher | Taylor & Francis/CRC Press |
| record_format | marc |
| spelling | Vascularization regenerative medicine and tissue engineering editor, Eric M. Brey Boca Raton, FL Taylor & Francis/CRC Press 2014 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index "The first federally-funded meeting on tissue engineering was in 1988. In this and subsequent meetings, the fields of tissue engineering and regenerative medicine (TERM) have been described as having the potential to revolutionize clinical approaches to the replacement, reconstruction or regeneration of organs and tissues. While TERM research has resulted in new patient treatments, the broad impact on clinical practice envisioned has not been achieved. The development of new TERM therapies that have significant clinical impact requires the ability to control vascularization, the process of new vessel assembly. The circulatory system plays a number of vital roles in regenerating and functioning tissues. It supplies oxygen and nutrients, removes wastes and is a source of multiple cell types required to respond to changing physiological conditions. For nearly every TERM application, the ability to enhance, regenerate or engineer new tissues requires spatial and temporal control over the process of vascularization. While vascularization is being studied in a number of physiologic and pathologic processes, TERM applications present distinct challenges. For example, unique microenvironmental conditions result from biomaterial and cell combinations used in TERM applications that are not encountered in any other system. In addition, clinical applications require vascularization of large tissue volumes within time frames that are much lower than those found during vascularization in development and typical physiologic processes. These requirements place significant constraints on the design of TERM therapies"--Provided by publisher Section 1. Cells -- section 2. Biomaterials -- section 3. Models -- section 4. Imaging -- section 5. Vascularized tissues Vascular Surgical Procedures / methods Blood Vessels / anatomy & histology Regenerative Medicine / methods Tissue Engineering / methods Tissue Transplantation HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Blood-vessels / Surgery fast Regenerative medicine fast Tissue engineering fast Evidenz-basierte Medizin Innere Medizin Medizin Blood-vessels Surgery Regenerative medicine Tissue engineering Tissue Engineering (DE-588)4646061-5 gnd rswk-swf Vaskularisation (DE-588)4187429-8 gnd rswk-swf Vaskularisation (DE-588)4187429-8 s Tissue Engineering (DE-588)4646061-5 s 1\p DE-604 Brey, Eric M. Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=798050 Aggregator Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Vascularization regenerative medicine and tissue engineering Vascular Surgical Procedures / methods Blood Vessels / anatomy & histology Regenerative Medicine / methods Tissue Engineering / methods Tissue Transplantation HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Blood-vessels / Surgery fast Regenerative medicine fast Tissue engineering fast Evidenz-basierte Medizin Innere Medizin Medizin Blood-vessels Surgery Regenerative medicine Tissue engineering Tissue Engineering (DE-588)4646061-5 gnd Vaskularisation (DE-588)4187429-8 gnd |
| subject_GND | (DE-588)4646061-5 (DE-588)4187429-8 |
| title | Vascularization regenerative medicine and tissue engineering |
| title_auth | Vascularization regenerative medicine and tissue engineering |
| title_exact_search | Vascularization regenerative medicine and tissue engineering |
| title_full | Vascularization regenerative medicine and tissue engineering editor, Eric M. Brey |
| title_fullStr | Vascularization regenerative medicine and tissue engineering editor, Eric M. Brey |
| title_full_unstemmed | Vascularization regenerative medicine and tissue engineering editor, Eric M. Brey |
| title_short | Vascularization |
| title_sort | vascularization regenerative medicine and tissue engineering |
| title_sub | regenerative medicine and tissue engineering |
| topic | Vascular Surgical Procedures / methods Blood Vessels / anatomy & histology Regenerative Medicine / methods Tissue Engineering / methods Tissue Transplantation HEALTH & FITNESS / Diseases / General bisacsh MEDICAL / Clinical Medicine bisacsh MEDICAL / Diseases bisacsh MEDICAL / Evidence-Based Medicine bisacsh MEDICAL / Internal Medicine bisacsh Blood-vessels / Surgery fast Regenerative medicine fast Tissue engineering fast Evidenz-basierte Medizin Innere Medizin Medizin Blood-vessels Surgery Regenerative medicine Tissue engineering Tissue Engineering (DE-588)4646061-5 gnd Vaskularisation (DE-588)4187429-8 gnd |
| topic_facet | Vascular Surgical Procedures / methods Blood Vessels / anatomy & histology Regenerative Medicine / methods Tissue Engineering / methods Tissue Transplantation HEALTH & FITNESS / Diseases / General MEDICAL / Clinical Medicine MEDICAL / Diseases MEDICAL / Evidence-Based Medicine MEDICAL / Internal Medicine Blood-vessels / Surgery Regenerative medicine Tissue engineering Evidenz-basierte Medizin Innere Medizin Medizin Blood-vessels Surgery Tissue Engineering Vaskularisation |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=798050 |
| work_keys_str_mv | AT breyericm vascularizationregenerativemedicineandtissueengineering |